MRG006A Combination Therapy for Advanced Hepatocellular Carcinoma (Phase I/II)

NCT07479485 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

NOT_YET_RECRUITING

Status

160

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatocellular Carcinoma

Interventions

DRUG: MRG006A
DRUG: MRG006A
DRUG: MRG006A

Sponsor

Lepu Biopharma Co., Ltd.